DESTINY R DANNELLS
- Type
- Non-physician practitioner · Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Family
- Where
- OLNEY, IL
- NPI
- 1427606920
- Received
- $1,361 in 76 records, 2021 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 24 | $493 |
| 2024 | General payment | 18 | $322 |
| 2023 | General payment | 23 | $366 |
| 2022 | General payment | 6 | $105 |
| 2021 | General payment | 5 | $73 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $451 | 2022–2025 |
| Teva Pharmaceuticals USA, Inc. | 20 | $302 | 2023–2025 |
| Alkermes, Inc. | 7 | $144 | 2023–2025 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 | 2022–2025 |
| Neurocrine BioSciences, Inc. | 5 | $79 | 2024–2025 |
| Lilly USA, LLC | 5 | $73 | 2021–2025 |
| Janssen Pharmaceuticals, Inc | 2 | $36 | 2023–2025 |
| Dexcom, Inc. | 2 | $34 | 2021 |
| Novo Nordisk Inc | 2 | $32 | 2021–2023 |
| Collegium Pharmaceutical, Inc. | 2 | $31 | 2025 |
| Vanda Pharmaceuticals Inc. | 1 | $27 | 2025 |
| Insulet Corporation | 1 | $20 | 2025 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 76 | $1,361 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-28 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-25 | Collegium Pharmaceutical, Inc. | $15 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-27 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-21 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-08-14 | Collegium Pharmaceutical, Inc. | $15 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-24 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-07-21 | Vanda Pharmaceuticals Inc. | $27 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-05-21 | Otsuka America Pharmaceutical, Inc. | $27 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-05 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-27 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-03-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-17 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-02-25 | Insulet Corporation | $20 | Food and Beverage | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2025 | |
| 2025-02-23 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-02-20 | Alkermes, Inc. | $15 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-02-03 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-23 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-01-16 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2024-12-19 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-12-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-12-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $0 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-31 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-22 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-08-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-11 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-05-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-03-11 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-02-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-18 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-02-18 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-01-11 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2023-12-11 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-12-07 | Teva Pharmaceuticals USA, Inc. | $31 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-11-25 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-11-24 | Teva Pharmaceuticals USA, Inc. | $5 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-11-17 | Janssen Pharmaceuticals, Inc | $21 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-11-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-13 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-11-11 | Teva Pharmaceuticals USA, Inc. | $8 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-10-30 | Alkermes, Inc. | $25 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-10-29 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-10-29 | Teva Pharmaceuticals USA, Inc. | $4 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-10-12 | Alkermes, Inc. | $16 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-09-25 | Teva Pharmaceuticals USA, Inc. | $4 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-09-23 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-07-20 | Teva Pharmaceuticals USA, Inc. | $8 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-07-20 | Teva Pharmaceuticals USA, Inc. | $2 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-05-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-05-18 | Lilly USA, LLC | $12 | Food and Beverage | In-kind items and services | TRULICITY Drug, Diabetes | 2023 | |
| 2023-05-05 | Teva Pharmaceuticals USA, Inc. | $10 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-04-20 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-03-14 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | TRULICITY Drug, Diabetes | 2023 | |
| 2023-01-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-01-06 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2022-11-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-10-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-09-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-09-23 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2022 | |
| 2022-08-10 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-01-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2021-06-03 | Dexcom, Inc. | $13 | Food and Beverage | In-kind items and services | DEXCOM G6 TRANSMITTER Device, ENDOCRINOLOGY | 2021 | |
| 2021-04-08 | Lilly USA, LLC | $12 | Food and Beverage | In-kind items and services | TRULICITY Drug, Diabetes | 2021 | |
| 2021-03-17 | Dexcom, Inc. | $20 | Food and Beverage | In-kind items and services | DEXCOM G6 TRANSMITTER Device, ENDOCRINOLOGY | 2021 | |
| 2021-02-09 | Lilly USA, LLC | $11 | Food and Beverage | In-kind items and services | TRULICITY Drug, Diabetes | 2021 | |
| 2021-01-27 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Olney, IL, county Richland County, IL, state Illinois; placed by its city name.
| Measure | Place (city or town) Olney, IL | County Richland County, IL | State Illinois |
|---|---|---|---|
| Population B01003 | 8,577 | 15,598 | 12,694,798 |
| Population, 2020 census P1 | 8,701 | 15,813 | 12,812,508 |
| Median age B01002 | 41.0 | 42.3 | 39.0 |
| Under 18 B01001 | 23.8% | 23.0% | 21.8% |
| 65 and over B01001 | 21.6% | 20.7% | 17.0% |
| Households B11001 | 3,599 | 6,443 | 5,036,449 |
| Foreign born B05002 | 2.3% | 1.4% | 14.7% |
| Median household income B19013 | $59,980 | $62,455 | $83,390 |
| Median family income B19113 | $80,192 | $80,014 | $106,018 |
| Per capita income B19301 | $32,779 | $33,126 | $46,406 |
| Poverty rate B17001 | 14.2% | 12.1% | 11.8% |
| Unemployment rate B23025 | 4.7% | 3.1% | 5.8% |
| Civilian labor force B23025 | 4,016 | 7,649 | 6,652,134 |
| Mean commute (minutes) B08013 | 17.2 | 19.7 | 27.8 |
| Bachelor's degree or higher B15003 | 21.2% | 19.1% | 37.8% |
| Housing units B25001 | 4,153 | 7,363 | 5,457,452 |
| Owner-occupied B25003 | 65.4% | 73.8% | 67.1% |
| Renters B25003 | 34.6% | 26.2% | 32.9% |
| Median home value B25077 | $99,800 | $112,000 | $263,300 |
| Median gross rent B25064 | $809 | $805 | $1,274 |
| White, not Hispanic B03002 | 91.7% | 93.4% | 58.1% |
| Black B03002 | 0.5% | 0.3% | 13.3% |
| Hispanic or Latino B03002 | 2.8% | 2.0% | 18.8% |
| Asian B03002 | 0.8% | 0.5% | 5.9% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Economy now FRED unemployment 4.6% in Sep 2026 (4.5% a year earlier); per capita personal income $78,987 in 2025, up 28% in five years (+3.1% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Olney, IL.
Comments